OBJECTIVE. The purpose of our study was to evaluate the usefulness of MR ch
olangiopancreatography in the diagnosis and further treatment of patients w
ith failed or inadequate ERCP.
SUBJECTS AND METHODS. Fifty-eight patients with failed or inadequate ERCP u
nderwent MR cholangiopancreatography using a two-dimensional heavily T2-wei
ghted multislice fast spin-echo technique. The final diagnosis was made on
the basis of a second ERCP (n = 4), percutaneous transhepatic cholangiopanc
reatography (n = 19), intraoperative cholangiography (n = 6), percutaneous
biopsy (n = 3), surgical findings (n = 5), or clinical follow-up (n = 21) f
or a mean period of 22 months (range, 7-31 months).
RESULTS. MR cholangiopancreatography was technically successful in 57 patie
nts and resulted in a sensitivity, specificity, and diagnostic accuracy of
97.1%, 100%, and 98.2%, respectively. Overall, MR cholangiopancreatography
gave clinically useful information that contributed to patient management i
n 56 (96.6%) of the 58 patients. On the basis of the MR cholangiopancreatog
raphy findings, patients were managed using a second ERCP (n = 4), combined
percutaneous and endoscopic procedure (n = 2), percutaneous biliary stent
insertion (n = 13), surgery (n = 12), chemotherapy (n = 1), or conservative
treatment (n = 24).
CONCLUSION. MR cholangiopancreatography was found to have a unique and valu
able role in the investigation of patients in whom ERCP failed or was inade
quate. MR cholangiopancreatography helped us avoid using invasive procedure
s such as percutaneous transhepatic cholangiography in the diagnosis of bil
e duct disease after failed ERCP.